ArticleScientific reports2017

Suppression of the FA pathway combined with CHK1 inhibitor hypersensitize lung cancer cells to gemcitabine.

Chun-Hua Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.